DK1948131T3 - Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer - Google Patents

Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer

Info

Publication number
DK1948131T3
DK1948131T3 DK06818627T DK06818627T DK1948131T3 DK 1948131 T3 DK1948131 T3 DK 1948131T3 DK 06818627 T DK06818627 T DK 06818627T DK 06818627 T DK06818627 T DK 06818627T DK 1948131 T3 DK1948131 T3 DK 1948131T3
Authority
DK
Denmark
Prior art keywords
calcium
pharmaceutical composition
dexpanthenol
well
chelating agents
Prior art date
Application number
DK06818627T
Other languages
Danish (da)
English (en)
Inventor
Frank Holzer
Dorothea Gross
Original Assignee
Ursapharm Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37989463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1948131(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ursapharm Arzneimittel Gmbh filed Critical Ursapharm Arzneimittel Gmbh
Application granted granted Critical
Publication of DK1948131T3 publication Critical patent/DK1948131T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK06818627T 2005-11-17 2006-11-17 Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer DK1948131T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005055275A DE102005055275A1 (de) 2005-11-17 2005-11-17 Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
PCT/EP2006/011053 WO2007057201A2 (de) 2005-11-17 2006-11-17 Dexpanthenol-, calciumionen- und phosphatfreie pharmazeutische zusammensetzung sowie verwendung von calcium-chelatbildner und ophthalmologisch verträglichem viskositätsregler

Publications (1)

Publication Number Publication Date
DK1948131T3 true DK1948131T3 (da) 2009-07-13

Family

ID=37989463

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06818627T DK1948131T3 (da) 2005-11-17 2006-11-17 Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer

Country Status (15)

Country Link
US (1) US8648057B2 (zh)
EP (1) EP1948131B3 (zh)
JP (1) JP2009515921A (zh)
CN (1) CN101312711B (zh)
AT (1) ATE425742T1 (zh)
CA (1) CA2630193C (zh)
CY (1) CY1109112T1 (zh)
DE (2) DE102005055275A1 (zh)
DK (1) DK1948131T3 (zh)
ES (1) ES2324118T7 (zh)
HK (1) HK1125027A1 (zh)
PL (1) PL1948131T6 (zh)
PT (1) PT1948131E (zh)
SI (1) SI1948131T1 (zh)
WO (1) WO2007057201A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20070208A1 (it) * 2007-06-19 2008-12-20 Alessandro Filippo Metodo di umidificazione di una lente a contatto
MX349176B (es) 2008-09-22 2017-07-14 Biochemics Inc Suministro transdermico de farmaco empleando un osmolito y un agente vasoactivo.
DE102009021372A1 (de) 2009-05-14 2010-11-18 Ursapharm Arzneimittel Gmbh Phosphatfreie pharmazeutische Zusammensetzung zur Glaukombehandlung
AT511164A1 (de) 2011-03-03 2012-09-15 Croma Pharma Gmbh Verwendung eines viskoelastischen fluids zur herstellung eines medizinproduktes für die chirurgische behandlung des auges
PL3019177T3 (pl) 2013-07-10 2021-04-19 Matrix Biology Institute Kompozycje hialuronianu o dużej sprężystości i ich zastosowania
FR3019465B1 (fr) 2014-04-02 2017-06-23 Horus Pharma Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
CN108135926A (zh) 2015-09-24 2018-06-08 基质生物研究所 高弹性透明质酸组合物及其使用方法
ITUB20160543A1 (it) * 2016-02-08 2017-08-08 Sooft Italia S P A 63833 Montegiorgio Fermo / Italia Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali
CA3055523A1 (en) 2017-03-05 2018-09-13 Resdevco Research And Development Co. Ltd. Eye drops for treatment of irritation not due to infection
EP3691654A4 (en) 2017-09-25 2021-11-24 Surface Pharmaceuticals, Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES
CN112292135A (zh) * 2018-04-18 2021-01-29 I.Com医疗有限责任公司 用于治疗和预防严重眼表疾病的高分子量透明质酸
WO2019210352A1 (en) * 2018-05-01 2019-11-07 Jinan Cao Eye drops that cure cataracts presbyopia and
RU2679319C1 (ru) * 2018-11-27 2019-02-07 Илья Александрович Марков Гелеобразная искусственная слеза с антисептическим и репаративным действием

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
WO1984004681A1 (en) * 1983-05-25 1984-12-06 Alcon Lab Inc Ophthalmic solution
US4629623A (en) * 1984-06-11 1986-12-16 Biomatrix, Inc. Hyaluronate-poly (ethylene oxide) compositions and cosmetic formulations thereof
US5705485A (en) * 1987-09-18 1998-01-06 Ethicon, Inc. Gel formulations containing growth factors
JPH075456B2 (ja) 1988-10-01 1995-01-25 参天製薬株式会社 点眼液
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
DE69017559T3 (de) * 1989-07-24 2002-06-06 Allergan Pharmaceuticals Irela Stabile Lösung von Hyaluronat in einem isotonen Salzmilieu.
EP0464727B1 (en) 1990-06-29 1996-01-03 Santen Pharmaceutical Co., Ltd. Use of a composition for the preparation of a medicament for debridment of retained lens material
JPH0748262A (ja) * 1993-06-04 1995-02-21 Senju Pharmaceut Co Ltd 外眼部投与用組成物
IT1273011B (it) 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19729879C2 (de) * 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
AU2001285006A1 (en) * 2000-08-21 2002-03-04 Bausch And Lomb Surgical, Inc. Prevention of posterior capsular opacification by endocapsular circulation of chemical agents
AU2002228449B2 (en) * 2001-01-09 2007-12-06 Louis Johan Wagenaar Procedure and composition of treatment and/or care of the eye
JP2003002837A (ja) * 2001-06-21 2003-01-08 Lion Corp 水性外用剤組成物及び液体組成物の白濁防止方法
DE10161149B4 (de) * 2001-12-12 2007-03-08 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Heparin-haltigem Ophthalmikum
DE10161110A1 (de) * 2001-12-12 2003-06-26 Ursapharm Arzneimittel Gmbh Pharmazeutische Zusammensetzung zur ophthalmologischen und rhinologischen Anwendung
JP2003206241A (ja) 2002-01-11 2003-07-22 Teika Seiyaku Kk 眼科用剤
JP4263456B2 (ja) * 2002-03-18 2009-05-13 わかもと製薬株式会社 ヒアルロン酸含有熱ゲル化製剤
JP2004059432A (ja) 2002-06-04 2004-02-26 Rohto Pharmaceut Co Ltd 角膜障害治療剤
JP4603976B2 (ja) * 2002-10-31 2010-12-22 千寿製薬株式会社 角膜障害治療剤
GB0225518D0 (en) 2002-11-01 2002-12-11 Airbus Uk Ltd Welding method
US7083803B2 (en) * 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
WO2005042026A1 (ja) * 2003-10-31 2005-05-12 Wakamoto Pharmaceutical Co., Ltd. 可逆性熱ゲル化水性組成物
JP2005239622A (ja) 2004-02-26 2005-09-08 Rohto Pharmaceut Co Ltd 角膜障害治療剤
CA2563882A1 (en) * 2004-04-23 2005-11-03 Senju Pharmaceutical Co., Ltd. Corneal neuritogenesis promoter containing pacap and its derivative
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes

Also Published As

Publication number Publication date
CN101312711B (zh) 2013-07-17
HK1125027A1 (en) 2009-07-31
DE102005055275A1 (de) 2007-05-24
CA2630193A1 (en) 2007-05-24
WO2007057201A3 (de) 2007-08-02
CY1109112T1 (el) 2014-07-02
US20090111770A1 (en) 2009-04-30
SI1948131T1 (sl) 2009-08-31
PL1948131T3 (pl) 2009-08-31
EP1948131B1 (de) 2009-03-18
DE502006003215D1 (de) 2009-04-30
ATE425742T1 (de) 2009-04-15
WO2007057201A2 (de) 2007-05-24
CA2630193C (en) 2015-05-19
CN101312711A (zh) 2008-11-26
PL1948131T6 (pl) 2013-09-30
EP1948131A2 (de) 2008-07-30
ES2324118T7 (es) 2013-07-30
US8648057B2 (en) 2014-02-11
PT1948131E (pt) 2009-06-12
JP2009515921A (ja) 2009-04-16
EP1948131B3 (de) 2013-03-27
ES2324118T3 (es) 2009-07-30

Similar Documents

Publication Publication Date Title
DK1948131T3 (da) Dexpanthenol-, calciumion- og phosphatfri farmaceutisk sammensætning samt anvendelse af calciumchelatdannere og oftalmologisk kompatible viskositetsregulatorer
FR21C1064I2 (fr) Compositions et procedes de traitement de troubles impliquant une proliferation cellulaire
JOP20210060A1 (ar) معدلات لمضاد تريبسين ألفا-1
NO20063147L (no) Antivirale farmasoytiske blandinger
TNSN07005A1 (fr) Analogues tetrapeptidiques
GT200600009A (es) Amino-imidazolonas para la inhibicion de beta-secretasa
CL2009001993A1 (es) Compuestos derivados de 6-oxo-4-fenilamino-1,6-dihidropiridina-3-amida, inhibidores de mek; proceso de preparacion de estos, utiles en el tratamiento de un trastorno hiperproliferativo o una condicion inflamatoria. (divisional de la solicitud cl 1168-06)
NO20075647L (no) Kjemiske forbindelser
NO20092609L (no) Tannate salt of rasagiline
CL2007002705A1 (es) Composicion farmaceutica oftalmica autopreservada que comprende 0,04 a 0,9 mm de iones zinc donde la concentracion de aniones tamponantes es menor que 15 mm.
WO2003105840A3 (en) SPHINGOSINE KINASE INHIBITORS
ATE478863T1 (de) Heterotetracyclische verbindungen als tpo- mimetica
IL190632A0 (en) Biphenyl derivatives and pharmaceutical compositions containing the same
CR10766A (es) Inhibidores de metaloproteasa derivados de heterociclicos
EA200970377A1 (ru) Композиции фенилалкиламинокарбамата
UA89201C2 (ru) Энантиомеры выбранных конденсированных пиримидонов и их применение для лечения и профилактики злокачественного новообразования
WO2008057293A3 (en) Methods and compositions for prion decontamination
TW200730468A (en) Methods for providing oxidatively stable ophthalmic compositions
CY1105166T1 (el) Ενωσεις φωσφονικου οξεος σαν αναστολεις πρωτεασων σepινης
PH12020552172A1 (en) Cyclic dinucleotides as sting agonists
NO20055396D0 (no) Nye fosfonsyreforbindelser som erinproteaseinhibitorer
MX2020005500A (es) Derivados novedosos de piperidinilo como inhibidores de la proteasa 7 ubiquitina especifica.
UA96269C2 (uk) Інгібітори цистеїнпротеази та їх терапевтичне застосування
MX2008007195A (es) Inhibidores de proteasas de cisteina, composiciones farmaceuticas de las mismas y sus aplicaciones terapeuticas.
PH12020551290A1 (en) Novel inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodontal and related diseases